Titan Pharmaceuticals Inc (TTNP NASDAQ) stock market data APIs
$4.4448
0(0%)
as of July 8, 2025
Try our APIs with
free plan!
Titan Pharmaceuticals Inc Financial Data Overview
Price chart is built with
Anychart
Titan Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the development of therapeutics for the treatment of chronic diseases. Titan Pharmaceuticals, Inc. was founded in 1991 and is based in New York, New York.
Prev. Close
4.4448
Open
4.4448
High
4.4448
Low
4.4448
52 wk Range
3.03-14.8
Market Cap
5 920 K
Shares Outstanding
1 330 K
Revenue
3 000
EPS
-0.62
Beta
1.306
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Titan Pharmaceuticals Inc data using free add-ons & libraries
Get Titan Pharmaceuticals Inc Fundamental Data
Titan Pharmaceuticals Inc Fundamental data includes:
- Net Revenue: 3 000
- EBITDA: -4 023 750
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-14
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Titan Pharmaceuticals Inc News
New
Titan Pharmaceuticals announces $600,000 private placement
* Titan Pharmaceuticals (NASDAQ:TTNP [https://seekingalpha.com/symbol/TTNP]) announced on Friday that it has completed a private placement of the company’s newly designated series C convertible pr...
Titan Pharmaceuticals Announces $600,000 Private Placement of Convertible Preferred Stock
NEW YORK, June 27, 2025 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") announced today that, pursuant to a securities purchase agreement (the “Purchase A...
Titan Pharmaceuticals shareholders approve all proposals at annual meeting
Titan Pharmaceuticals, Inc. (NASDAQ:TTNP), a micro-cap pharmaceutical company with a market capitalization of $5.13 million and a notable year-to-date stock performance of 35%, announced that sharehol...
Titan announces filing of registration statement for proposed combination
Titan Pharmaceuticals (TTNP) announced the filing by Black Titan Corporation with the U.S. Securities and Exchange Commission of a registration statement on Form F-4 in connection with the proposed co...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
